Ürosepsis

Braissant O, Müller G, Egli A, et al. Seven Hours to Adequate Antimicrobial Therapy in Urosepsis Using Isothermal Microcalorimetry. J Clin Microbiol 2014; 52 (2): 624-626.

Ertuğrul MB. Ürosepsis. Türkiye Klinikleri J Surg Med Sci 2007; 3 (20): 29-32.

KLİMUD. Klinik Örnekten Sonuç Raporuna Uygulama Rehberi (30/01/2023 tarihinde http://klimud.org/public/uploads/files/urinersistemornekleri_03092014.pdf. adresinden ulaşılmıştır).

Dökmetaş İ, Bakır M, Bakıcı MZ, ve ark. Ürosepsis: 41 Olgunun Değerlendirilmesi. Klimik Derg 1995; 8 (1): 20-22.

Kumar S, Dave A, Wolf B, et al. Urinary Tract Infections. Dis Mon 2015; 61 (2): 45-59.

van der Starre W, van Nieuwkoop C, Thomson U, et al. Urinary Proteins, Vitamin D and Genetic Polymorphisms as Risk Factors for Febrile Urinary Tract Infection and Relation with Bacteremia: A Case Control Study. PLoS ONE 2015; 10 (3): e0121302. (doi:10.1371/journal.pone.0121302)

Kiraz A, Vural A, Tekin SZ, ve ark. An Overview to Urine Culture in Pregnancy. GARJM 2014; 3 (9): 160-162.

Kline KA, Lewıs AL. Gram-positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract. Microbiol Spec 2016; 4 (2). (doi:10.1128/microbiolspec.UTI-0012-2012).

İnci M, İnci M, Davarcı M. Gebelikte Görülen Üriner Sistem Enfeksiyonları ve Tedavisi. Turk Urol Sem 2011; 2: 124-126.

Johansen TE, Botto H, Cek M, et al. Critical Review of Current Definitions of Urinary Ttract Infections and Proposal of an EAU/ESIU Classification System. Int J Antimicrob Agents 2011; 38 Suppl: 64-70.

Kadanalı A. Urinary Tract Infections. EAJM 2006; 38: 119-123.

Thomas L, Tracy CR. Treatment of Fungal Urinary Tract Infection. Urol Clin N Am 2015; 42: 473-483.

Wagenlehner FME, Weidner W, Naber KG. Pharmacokinetic Characteristics of Antimicrobials and Optimal Treatment of Urosepsis. Clin Pharmacokinet 2007; 46 (4): 291-305.

Wagenlehner FME, Lichtenstern C, Rolfes C, et al. Diagnosis and Management for Urosepsis. Int J Urol 2013; 20: 963-970.

Sugimoto K, Adomi S, Koike H, et al. Procalcitonin as an Indicator of Urosepsis. Res Rep Urol 2013; 26 (5): 77-80.

Wagenlehner FME, Pilatz A, Weidner W. Urosepsis-from the View of the Urologist. Int J Antimicrob Agents 2011; 38 Suppl: 51-57.

Wagenlehner FME, Pilatz A, Naber KG, et al. Therapeutic Challenges of Urosepsis. Eur J Clin Invest 2008; 38 (S2): 45-49.

Stalenhoef JE, van Dissel JT, van Nieuwkoop C. Febrile Urinary Tract Infection in the Emergency Room. Curr Opin Infect Dis 2015; 28 (1): 106-111.

van Nieuwkoop C, Bonten TN, van't Wout JW, et al. Procalcitonin Reflects Bacteremia and Bacterial Load in Urosepsis Syndrome: a Prospective Observational Study. Crit Care 2010; 14 (6): R206.

Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 23; 315 (8): 801-810.

Carmignani L, Picozzi S, Spinelli M, et al. Bacterial Sepsis Following Prostatic Biopsy. Int Urol Nephrol 2012; 44 (4): 1055-1063.

Guliciuc M, Maier AC, Maier IM, et al. The Urosepsis-A Literature Review. Medicina 2021;57: 872.